Orin
ARMNasdaq·Semiconductors

Arm Holdings plc ARM

Market cap $354.7BP/E 342.8× trailingGross margin 95.3%Reports Wed 4 Nov, before the open
$332.56
−0.64 (−0.19%)Wed close 16:00 ET
52-wk $100.02 – $452.70
Watch
Orin's take
0.62conviction · moderate
Refreshed 16 Aug · take v3. A new filing or a print queues the next refresh.

Arm Holdings' fundamentals are genuinely impressive—FY2026 revenue grew 22.8% to $4.92B with 92.5% gross margins and FCF rebounding to $979M from $178M—but at $279.44 the stock trades at 288x trailing earnings and 58x sales, roughly 5x peer median multiples, pricing in years of flawless execution. The stock has recovered ~24% from the prior hold call at $224.89, with MACD turning bullish and RSI neutral at 50, but persistent insider selling ($118.5M net disposition over 24 months, including the CPO liquidating entirely) and the extreme valuation leave no margin of safety.

The AI-driven CPU growth thesis is intact, but patience remains the prudent stance until either multiples compress materially or earnings growth catches up to the price.

What could go wrong

  • Extreme valuation. P/E of 288x and P/S of 58x are ~5x peer medians (42x PE, 9x PS); any growth disappointment could trigger a sharp de-rating.
  • Persistent insider selling. Net $118.5M in dispositions over 24 months across multiple executives, including the Chief People Officer selling to zero shares and the CCO selling at $287-$393.
  • Revenue growth deceleration. Revenue growth has been strong but quarterly trajectory has been choppy with sequential declines, unlike more consistent peers; any slowdown would be severely punished at this multiple.
  • Smart money is lukewarm. Smart money score of 0.0557 as of March 2026 is barely positive and the data is stale; fund count rose to 47 from 28 but conviction remains low.

What would change my mind

Valuation compression. Stock pulls back below $200 (near 200-day MA of $195) while fundamentals hold, bringing P/E toward a more defensible ~235xbullish
Sustained insider buying. Insiders shift from net selling to net open-market purchases, signaling confidence at current levelsbullish
Revenue growth miss. FY2027 revenue growth falls below 20% or royalty rate pressures compress gross margins below 90%bearish

Where this comes from: Orin fundamentals FY2026 vs FY2025 · Orin fundamentals FY2026 · Orin fundamentals FY2026 vs FY2025 · Orin peer_relative. Orin's read on ARM; not advice.

Twelve months actual closes to 2026-09-23 · actual filings

Sept 25Nov 25Jan 26Mar 26May 26Jul 26

50-day average 200-day average · volume below

FormFiledWhat it saysRead
13G14 Feb 2024on file

Largest holders · 13F Q2 2026

Money flow
FilerPositionOf fund
Invesco$4.5B0.4% of fund
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main$2.3B1.8% of fund
Capital World Investors$1.5B0.2% of fund
Fmr$1.4B0.1% of fund
Goldman Sachs Group$1.0B0.1% of fund
Capital Research Global Investors$851.4M0.1% of fund

87 filers · quarter ended Q2 2026 · positions, not flows

Insiders, last 24 months: 124 Form 4 filings, net −$124.5M. Of the 50 on hand, 0 were open-market purchases and 15 sales— the rest are grants, option exercises and tax withholding.

Ask Orin about ARM

its filings · its transcripts · its numbers

Orin answers questions about ARM from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

Start 3 free days

Where it trades

· Technology
MetricNowOwn medianSector
P/E342.8×53.3×
EV/EBITDA256.8×
P/S68.89×
P/B41.1×
What the price assumes

49.1%

free-cash-flow growth every year for 10 years, discounted at 10%, is what today’s price implies — starting from $1.0B of trailing free cash flow. It is an assumption the market is making, not a forecast Orin is making.

What Wall Street published

27 firms · 2026-09-23
Consensus target

$363

$210$641 · +9% against today's price

How they rate it
  • 19 buy or overweight
  • 6 hold
  • 2 underweight or sell

The analysts’ consensus and their own ratings, not Orin’s. A target is a twelve-month opinion published by the firm that wrote it.

Against the companies it is compared to

median P/E 40.9× of 8 peers
CompanyMarket capP/EEV/EBITDAGrossNetROE
ARMArm Holdings plc American Depositary Shares$355B342.8×256.8×95.3%20.2%13%
AMATApplied Materials, Inc.$377B40.6×33.1×49.4%30.1%40%
APHAmphenol Corporation$203B39.1×23.1×38.5%17.8%37%
INTCIntel Corporation$618B178.7×38.9%-19.8%-11%
INTUIntuit Inc.$78B17.4×11.4×80.9%21.3%23%
KLACKLA Corporation$245B51.0×43.4×61.3%35.6%85%
LRCXLam Research Corporation$384B53.1×44.0×50.5%31.3%67%
NOWServiceNow, Inc.$146B87.4×43.4×74.8%11.3%14%
QCOMQUALCOMM Incorporated$207B22.5×16.2×54.2%21.0%37%
TXNTexas Instruments Incorporated$249B41.2×28.5×58.3%31.1%36%

The median is of the 8 peers listed above and nothing else — check it against the column. This company trades 737.3% above it. The peer set is the vendor’s, so a company can appear here that a person would not have chosen.

What it has traded at

P/E by fiscal year
FY21 159.9×FY26 178.0×

What its sector has traded at

Technology
FY14 9.0×FY26 48.0×

Two scales, drawn separately on purpose: a sector median and one company’s multiple are not the same number and putting them on one axis invites a comparison neither series supports.

Every estimate on one scale

price $332.56
52-week range$100 – $453
Analyst targets$210 – $641
At sector P/E (53×)$52

The vertical rule is the current price. Ranges and point estimates are the backend’s, published as they were calculated; an arrow means the estimate sits beyond this scale, and its number is on the right.